Is a single medication sufficient to treat attention‑deficit/hyperactivity disorder, major depressive disorder, and generalized anxiety disorder?

No, a Single Medication is Generally Not Sufficient for ADHD, MDD, and GAD

The evidence clearly indicates that no single medication effectively treats all three conditions—ADHD, major depressive disorder, and generalized anxiety disorder—simultaneously. 1 You will need a sequential or combination approach.

Treatment Algorithm

Step 1: Determine Primary Disorder Severity

If MDD is severe (with psychosis, suicidality, or severe neurovegetative signs):

• Treat MDD first with an antidepressant (SSRI preferred)
• Address ADHD and GAD after MDD stabilizes 1

If MDD is less severe or ADHD symptoms are equally/more impairing:

• Start with stimulant medication for ADHD first 1

Step 2: Initial Stimulant Trial for ADHD

Begin with methylphenidate or amphetamine-based stimulants as first-line treatment:

• Methylphenidate: 5-20 mg three times daily, or
• Dexamphetamine: 5 mg three times daily to 20 mg twice daily 1

Critical advantage: Stimulants have rapid onset, allowing quick assessment of ADHD symptom response. Reducing ADHD-related morbidity can substantially improve depressive symptoms as a secondary benefit 1.

Step 3: Reassess After Stimulant Trial

If both ADHD and depressive symptoms remit:

• Continue stimulant monotherapy
• Monitor anxiety symptoms 1

If ADHD improves but MDD persists:

• Add an SSRI antidepressant to the stimulant
• Consider psychotherapy (cognitive behavioral therapy or interpersonal therapy) 1

If ADHD improves but GAD remains problematic:

• First attempt psychosocial intervention for anxiety
• If anxiety is severe or doesn't respond to non-pharmacological treatment, add an SSRI to the stimulant 1

Step 4: Alternative First-Line Approach (If Stimulants Contraindicated)

If stimulants cannot be used, consider atomoxetine as first-line:

• Atomoxetine may be particularly useful when comorbid anxiety is prominent 2, 3
• Effect size is smaller (0.7) compared to stimulants (1.0) 4
• Requires 6-12 weeks to observe full effects 2

Key Evidence Points

The guideline explicitly states: "No data support a single antidepressant to treat both ADHD and MDD." 1 While bupropion and tricyclics have antidepressant activity in adults, they are second-line agents at best for ADHD and have not proven effective for pediatric depression.

For comorbid anxiety: Recent large trials (MTA study) showed that ADHD children with comorbid anxiety actually had better treatment responses to stimulants than previously thought 1. Early concerns about reduced stimulant efficacy in anxious patients have not been replicated 1.

Recent evidence (2025) confirms that stimulant medications for ADHD are associated with reduced risk of depression (pooled RR = 0.80) 5, supporting the approach of treating ADHD first when both conditions coexist.

Common Pitfalls to Avoid

1. Don't wait indefinitely for one medication to treat everything—combination therapy is the expected outcome, not the exception
2. Don't assume anxiety will worsen with stimulants—this outdated concern has been disproven 1
3. Don't use bupropion or tricyclics as first-line for this combination—they lack evidence for treating all three conditions effectively 1
4. Don't delay treatment of severe MDD—if depression includes suicidality or psychosis, it takes priority 1

Bottom Line

You will almost certainly need at least two medications: a stimulant (or atomoxetine) for ADHD plus an SSRI for MDD/GAD. The specific sequence depends on which disorder causes the most functional impairment, but starting with a stimulant trial is advantageous when MDD is not severe, as ADHD improvement often reduces depressive symptoms secondarily.